Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APERIO® HYBRID Thrombectomy Device for Flow Restoration in Vessels of Patients Experiencing Acute Ischemic Stroke

NCT04457479 is registered in ClinicalTrials.gov with Acandis GmbH as lead sponsor.

NCT NCT04457479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04457479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APERIO® HYBRID Thrombectomy Device for Flow Restoration in Vessels of Patients Experiencing Acute Ischemic Stroke
Lead sponsor
Acandis GmbH
Phase
Observational
Overall status
Completed
Start date
November 2, 2020
Completion date
June 30, 2023
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke